These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32561493)

  • 1. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
    Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
    Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
    Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
    Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incretin hormone expression in the gut of diabetic mice and rats.
    Berghöfer P; Peterson RG; Schneider K; Fehmann HC; Göke B
    Metabolism; 1997 Mar; 46(3):261-7. PubMed ID: 9054467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
    Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion.
    Panaro BL; Yusta B; Matthews D; Koehler JA; Song Y; Sandoval DA; Drucker DJ
    Mol Metab; 2020 Jul; 37():100990. PubMed ID: 32278655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
    Badole SL; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Jangam GB; Ghule AE; Raut CG; Khedkar VM; Coutinho EC
    Chem Biol Interact; 2013 Apr; 203(2):530-41. PubMed ID: 23466488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal mTOR regulates GLP-1 production in mouse L cells.
    Xu G; Li Z; Ding L; Tang H; Guo S; Liang H; Wang H; Zhang W
    Diabetologia; 2015 Aug; 58(8):1887-97. PubMed ID: 26037201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
    Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
    Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
    Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
    Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
    Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
    J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic modeling of a monoclonal antibody antagonist of glucagon receptor in male ob/ob mice.
    Lau YY; Ma P; Gibiansky L; Komorowski R; Wang J; Wang G; Yan H; Véniant MM; Kakkar T
    AAPS J; 2009 Dec; 11(4):700-9. PubMed ID: 19851873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin.
    Iida A; Seino Y; Fukami A; Maekawa R; Yabe D; Shimizu S; Kinoshita K; Takagi Y; Izumoto T; Ogata H; Ishikawa K; Ozaki N; Tsunekawa S; Hamada Y; Oiso Y; Arima H; Hayashi Y
    Diabetologia; 2016 Jul; 59(7):1533-1541. PubMed ID: 27053237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys.
    Okamoto H; Kim J; Aglione J; Lee J; Cavino K; Na E; Rafique A; Kim JH; Harp J; Valenzuela DM; Yancopoulos GD; Murphy AJ; Gromada J
    Endocrinology; 2015 Aug; 156(8):2781-94. PubMed ID: 26020795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.